Dachaigh › Galar Depressive Mòr › Maryland
Sgrùdaidhean clionaigeach Galar Depressive Mòr ann an Maryland
Tha 21 sgrùdaidhean airson Galar Depressive Mòr a’ lorg phàirtichean aig làraichean ann an Maryland.
Bailtean ann an Maryland
Teacsa sgrùdaidh oifigeil (Beurla)
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
- National Institutes of Health Clinical Center, Bethesda
A’ fastadhÌre 2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06511908A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Sunstone Medical, PC, Rockville
A’ fastadhÌre 3
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06793397A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07412756NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
- National Institutes of Health Clinical Center, Bethesda
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 8 gu 70 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05669703A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07573176A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07775300Natural History of Depression, Bipolar Disorder and Suicide Risk
- National Institutes of Health Clinical Center, Bethesda
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06462196Characterization and Treatment of Adolescent Depression
- National Institutes of Health Clinical Center, Bethesda
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 11 gu 25 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT03388606A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Johns Hopkins University, Baltimore
A’ fastadhÌre 3
Aoisean 12 gu 17 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07227454A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Delricht Research - Rockville, Rockville
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07621237Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
- National Institutes of Health Clinical Center, Bethesda
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT03065335Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
- National Institutes of Health Clinical Center, Bethesda
- University of Maryland, College Park, College Park
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
Aoisean 8 gu 65 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT00018057Defining Neurobiological Links Between Substance Use and Mental Illness
- National Institute on Drug Abuse, Baltimore
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT05538910Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
- National Institutes of Health Clinical Center, Bethesda
A’ fastadhÌre 1
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 10 Sult 2026 · NCT03973268Neurobiology of Suicide
- National Institutes of Health Clinical Center, Bethesda
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT02543983A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Pharmasite Research Inc., Baltimore
A’ fastadhÌre 3
Aoisean 18 gu 74 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Gaithersburg
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07300969A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Continental Clinical Solutions, Towson
A’ fastadhÌre 2
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT07115329Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Pikesville
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT07484217Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Gaithersburg
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT06966401A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Sheppard Pratt, Baltimore
- Sunstone Medical, PC, Rockville
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 11 Cèit 2026 · NCT06524830Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.